Ingvil Sæterdal

1.6k total citations
38 papers, 1.2k citations indexed

About

Ingvil Sæterdal is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Ingvil Sæterdal has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Ingvil Sæterdal's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Ingvil Sæterdal is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Ingvil Sæterdal collaborates with scholars based in Norway, Switzerland and United States. Ingvil Sæterdal's co-authors include Gustav Gaudernack, Marianne Klemp, Jens Bjørheim, Erik Thorsby, Jon Amund Eriksen, June H. Myklebust, Bjarte G. Solheim, Jarle Breivik, Per thor Straten and Annika Lindblom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Annals of Internal Medicine.

In The Last Decade

Ingvil Sæterdal

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingvil Sæterdal Norway 14 569 538 299 285 159 38 1.2k
Yao Tettey Ghana 22 248 0.4× 217 0.4× 210 0.7× 174 0.6× 61 0.4× 55 1.3k
Helen E. Ownby United States 19 273 0.5× 218 0.4× 435 1.5× 110 0.4× 102 0.6× 33 1.6k
Der‐Cherng Liang Taiwan 21 395 0.7× 245 0.5× 1.2k 3.9× 571 2.0× 117 0.7× 81 2.6k
Siobhán O’Connor United States 19 221 0.4× 182 0.3× 250 0.8× 284 1.0× 79 0.5× 51 1.1k
Corinne Desaint France 13 270 0.5× 226 0.4× 160 0.5× 179 0.6× 74 0.5× 21 717
Hans‐Jürgen Laws Germany 17 254 0.4× 386 0.7× 279 0.9× 76 0.3× 67 0.4× 46 974
Barbara Zając United States 13 716 1.3× 310 0.6× 567 1.9× 128 0.4× 273 1.7× 34 1.3k
David Mesher United Kingdom 26 613 1.1× 124 0.2× 1.4k 4.6× 527 1.8× 117 0.7× 52 3.2k
Zhenggang Jiang China 17 103 0.2× 337 0.6× 293 1.0× 205 0.7× 25 0.2× 49 975
Michael Sandherr Germany 21 544 1.0× 125 0.2× 492 1.6× 115 0.4× 250 1.6× 35 1.2k

Countries citing papers authored by Ingvil Sæterdal

Since Specialization
Citations

This map shows the geographic impact of Ingvil Sæterdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingvil Sæterdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingvil Sæterdal more than expected).

Fields of papers citing papers by Ingvil Sæterdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingvil Sæterdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingvil Sæterdal. The network helps show where Ingvil Sæterdal may publish in the future.

Co-authorship network of co-authors of Ingvil Sæterdal

This figure shows the co-authorship network connecting the top 25 collaborators of Ingvil Sæterdal. A scholar is included among the top collaborators of Ingvil Sæterdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingvil Sæterdal. Ingvil Sæterdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sæterdal, Ingvil, et al.. (2022). Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices. International Journal of Technology Assessment in Health Care. 38(1). e78–e78. 10 indexed citations
2.
Bidonde, Julia, José F. Meneses-Echávez, Lumbwe Chola, et al.. (2022). Developing a tool to assess the skills to perform a health technology assessment. BMC Medical Research Methodology. 22(1). 78–78. 4 indexed citations
3.
Tafuri, Giovanni, Carlo Favaretti, Ansgar Hebborn, et al.. (2020). The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes. International Journal of Technology Assessment in Health Care. 36(3). 191–196. 1 indexed citations
4.
Pike, Eva, Vida Hamidi, Ingvil Sæterdal, Jan Odgaard‐Jensen, & Marianne Klemp. (2017). Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting. BMJ Open. 7(8). e014880–e014880. 18 indexed citations
5.
De‐Regil, Luz María, et al.. (2016). Fortification of wheat and maize flour with folic acid for population health outcomes. Cochrane Database of Systematic Reviews. 6 indexed citations
6.
Sæterdal, Ingvil, et al.. (2015). Effect of using aminoglycosides for treatment of sepsis. Duo Research Archive (University of Oslo). 1 indexed citations
7.
Sæterdal, Ingvil, et al.. (2014). Effect of catch-up HPV vaccination of young women. 1 indexed citations
8.
Couto, Elisabeth, Ingvil Sæterdal, Lene Kristine Juvet, & Marianne Klemp. (2014). HPV catch-up vaccination of young women: a systematic review and meta-analysis. BMC Public Health. 14(1). 867–867. 28 indexed citations
9.
Santesso, Nancy, Jonathan C. Hsu, Reem A. Mustafa, et al.. (2013). Antivirals for influenza: a summary of a systematic review and meta‐analysis of observational studies. Influenza and Other Respiratory Viruses. 7(s2). 76–81. 20 indexed citations
10.
Juvet, Lene Kristine, et al.. (2012). Pemetrexed as Maintenance Therapy for Advanced, Non-Squamous, Non-Small Cell Lung Cancer (NSCLC).
11.
Underland, Vigdis, Ingvil Sæterdal, & Elin Strømme Nilsen. (2012). Cochrane Summary of Findings: Horse Chestnut seed Extract for Chronic Venous Insufficiency. Global Advances in Health and Medicine. 1(1). 122–123. 8 indexed citations
12.
Hofmann, Bjørn, Rolv T. Lie, Inger Natvig Norderhaug, et al.. (2007). Mannlig infertilitet: Intracytoplasmatisk spermieinjeksjon (ICSI) med spermier uthentet fra bitestikkel eller testikkel. BIBSYS Brage (BIBSYS (Norway)). 1 indexed citations
13.
Alfsen, G. Cecilie, et al.. (2007). Prophylactic Vaccines Against Human Papillomavirus. 3 indexed citations
14.
Klemp, Marianne, Ingvil Sæterdal, Stein Sæbøe‐Larssen, & Gustav Gaudernack. (2003). HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes. Journal of Molecular Medicine. 81(1). 43–50. 23 indexed citations
15.
Hunger, Robert E., C.U. Brand, Michael Streit, et al.. (2001). Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM‐CSF as adjuvant. Experimental Dermatology. 10(3). 161–167. 33 indexed citations
16.
Sæterdal, Ingvil, Marianne Klemp, Per thor Straten, Jon Amund Eriksen, & Gustav Gaudernack. (2001). A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8 + T cells. Cancer Immunology Immunotherapy. 50(9). 469–476. 61 indexed citations
17.
Klemp, Marianne, Jens Bjørheim, Ingvil Sæterdal, June H. Myklebust, & Gustav Gaudernack. (1997). Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. International Journal of Cancer. 72(5). 784–790. 137 indexed citations
18.
Klemp, Marianne, Arne Bakka, Jarle Breivik, et al.. (1996). Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study. International Journal of Cancer. 65(4). 450–453. 91 indexed citations
19.
Sæterdal, Ingvil, et al.. (1996). Characterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccination. British Journal of Cancer. 74(11). 1828–1833. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao Tettey Breakdown of academic impact, for papers by Helen E. Ownby Breakdown of academic impact, for papers by Der‐Cherng Liang Breakdown of academic impact, for papers by Siobhán O’Connor Breakdown of academic impact, for papers by Corinne Desaint Breakdown of academic impact, for papers by Hans‐Jürgen Laws Breakdown of academic impact, for papers by Barbara Zając Breakdown of academic impact, for papers by David Mesher Breakdown of academic impact, for papers by Zhenggang Jiang Breakdown of academic impact, for papers by Michael Sandherr
Rankless by CCL
2026